Ibrutinib: The First Bruton's Tyrosine Kinase Inhibitor

Prescriber - United Kingdom
doi 10.1002/psb.1691
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Exerts Immunomodulatory Activity Towards Tumor-Infiltrating Macrophages

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Bruton's Tyrosine Kinase Inhibitor Restrains WNT Signaling in Chronic Lymphocytic Leukemia

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

SRC Family Protein Tyrosine Kinases Induce Autoactivation of Bruton's Tyrosine Kinase.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1995English

Inhibition of IgE-mediated Secretion From Human Basophils With a Highly Selective Bruton's Tyrosine Kinase, Btk, Inhibitor

International Immunopharmacology
AllergyImmunologyPharmacology
2011English

Activation Mechanism and Steady State Kinetics of Bruton's Tyrosine Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Bruton's Tyrosine Kinase Promotes Persistence of Mature Anti-Insulin B Cells

Journal of Immunology
AllergyImmunology
2014English

Bruton's Tyrosine Kinase Regulates Shigella Flexneri Dissemination in HT-29 Intestinal Cells

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2012English

A Highly Sensitive LC-MS/MS Method to Determine Novel Bruton's Tyrosine Kinase Inhibitor Spebrutinib: Application to Metabolic Stability Evaluation

Royal Society Open Science
Multidisciplinary
2019English

Tyrosine Kinase Inhibitor and Target Therapy

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy